Search research articles
Contact Us
Filters
Showing results (1-10 of 111) with videos related to
Page
of 12
Sort By:
Progress in Molecular Biology and Translational Science
|
March 23, 2025
Vaccines reimagined: The peptide revolution in disease prevention
Vivek P Chavda
Maturitas
|
March 4, 2022
Omicron variant (B.1.1.529) of SARS-CoV-2: Threat for the elderly?
Vivek P Chavda, Vasso Apostolopoulos
Nanomedicine (London, England)
|
August 18, 2023
Mosaic receptor binding domain nanoparticles: towards fourth-generation vaccination
Vivek P Chavda, Vasso Apostolopoulos
Maturitas
|
June 16, 2022
Rare monkeypox: Is it really a threat to the elderly?
Vivek P Chavda, Vasso Apostolopoulos
Vaccines
|
March 26, 2022
Is Booster Dose Strategy Sufficient for Omicron Variant of SARS-CoV-2?
Vivek P Chavda, Vasso Apostolopoulos
Expert Review of Vaccines
|
August 11, 2022
COVID-19 vaccine design and vaccination strategy for emerging variants
Vivek P Chavda, Vasso Apostolopoulos
Maturitas
|
August 8, 2021
Mucormycosis - An opportunistic infection in the aged immunocompromised individual: A reason for concern in COVID-19
Vivek P Chavda, Vasso Apostolopoulos
Maturitas
|
November 27, 2021
Reply to the letter 'Mucormycosis and black fungus: Breaking the myth'
Vivek P Chavda, Vasso Apostolopoulos
Progress in Molecular Biology and Translational Science
|
March 23, 2025
Peptides on patrol: Carrier systems for targeted delivery
Vivek P Chavda, Joanna Bojarska
Progress in Molecular Biology and Translational Science
|
March 23, 2025
Surface modified proteins and peptides for targeted drug delivery
Vivek P Chavda, Disha Joshi
Page
of 12
Search research articles
Search
Showing results (1-10 of 111) with videos related to
Sort By:
Page
of 12
Progress in Molecular Biology and Translational Science
|
March 23, 2025
Vaccines reimagined: The peptide revolution in disease prevention
Vivek P Chavda
Maturitas
|
March 4, 2022
Omicron variant (B.1.1.529) of SARS-CoV-2: Threat for the elderly?
Vivek P Chavda, Vasso Apostolopoulos
Nanomedicine (London, England)
|
August 18, 2023
Mosaic receptor binding domain nanoparticles: towards fourth-generation vaccination
Vivek P Chavda, Vasso Apostolopoulos
Maturitas
|
June 16, 2022
Rare monkeypox: Is it really a threat to the elderly?
Vivek P Chavda, Vasso Apostolopoulos
Vaccines
|
March 26, 2022
Is Booster Dose Strategy Sufficient for Omicron Variant of SARS-CoV-2?
Vivek P Chavda, Vasso Apostolopoulos
Expert Review of Vaccines
|
August 11, 2022
COVID-19 vaccine design and vaccination strategy for emerging variants
Vivek P Chavda, Vasso Apostolopoulos
Maturitas
|
August 8, 2021
Mucormycosis - An opportunistic infection in the aged immunocompromised individual: A reason for concern in COVID-19
Vivek P Chavda, Vasso Apostolopoulos
Maturitas
|
November 27, 2021
Reply to the letter 'Mucormycosis and black fungus: Breaking the myth'
Vivek P Chavda, Vasso Apostolopoulos
Progress in Molecular Biology and Translational Science
|
March 23, 2025
Peptides on patrol: Carrier systems for targeted delivery
Vivek P Chavda, Joanna Bojarska
Progress in Molecular Biology and Translational Science
|
March 23, 2025
Surface modified proteins and peptides for targeted drug delivery
Vivek P Chavda, Disha Joshi
Page
of 12